Safety and Efficacy of Recommended Regimens for Rapid Initiation of First-line ART

Review data on ART regimens for rapid initiation and considerations for choosing among recommended regimens
Gregory Huhn, MD, MPHTM
Format: Microsoft PowerPoint (.ppt)
File Size: 572 KB
Released: March 25, 2020

Acknowledgements

Provided by USF Health

USF Health
Office of Continuing Professional Development (OCPD)
124 S. Franklin Street
Tampa, FL 33602

(800) 852-5362
(813) 224-7860
(813) 224-7864 (Fax)
cpdsupport@usf.edu
https://health.usf.edu/cpd

Supported by an educational grant from
Janssen Therapeutics, Division of Janssen Products, LP

Related Content

CCO slides from Drs. Joseph J. Eron, Jr, and Darcy Wooten on the implications of emerging ART safety and tolerability data when managing HIV treatment

Joseph J. Eron, Jr., MD Darcy Wooten, MD Released: May 11, 2021

Clinical Care Options (CCO) video of faculty discussion on the implications of emerging ART safety and tolerability data when managing HIV treatment

Joseph J. Eron, Jr., MD Darcy Wooten, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 11, 2021 Expired: May 10, 2022

CCO commentary by Dr. Darcy Wooten on data presented at CROI 2021 regarding integrase strand inhibitor-associated weight gain and clinical implications

Darcy Wooten, MD Released: May 5, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue